Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Affymax Sell-Off: Did Investors Overreact?
Affymax Sell-Off: Did Investors Overreact?
Affymax Sell-Off: Did Investors Overreact?
Submitted by
admin
on July 8, 2010 - 9:27am
Source:
Seeking Alpha
News Tags:
Affymax
Amgen
Takeda
EPO
Epogen
Micera
Roche
investors
Headline:
Affymax Sell-Off: Did Investors Overreact?
Do Not Allow Advertisers to Use My Personal information
